Aqur Biosciences, Inc., 2026-09-18
An SEC Form D private-offering notice from Westlake Village, CA, a $1,500,000 filer-stated offering target in Biotech. Filed 2026-09-18. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Preclinical biopharmaceutical company developing AQR-008, an oral small molecule PCSK9 inhibitor to lower LDL cholesterol
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- NanosVet, Inc., 2026-09-18, $8.6M, Los Angeles, CA
- BioStem Technologies, Inc., 2026-09-21, $40M, Pompano Beach, FL
- SirenOpt Inc., 2026-09-18, $32.4M, San Leandro, CA
- Jupiter Biomedical Research, Inc., 2026-09-21, $1M, Palm Beach Gardens, FL
- Femtosense, Inc., 2026-09-18, $23.5M, San Bruno, CA
- Vicora, Inc., 2026-09-18, $2.5M, Buffalo, NY
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.